News
Eli Lilly’s (NYSE: LLY) latest acquisition has electrified the biotech world—and sent a clear message that gene editing is no longer just for rare diseases. The US pharma major is paying $1 billion ...
20h
MarketBeat on MSNGoldman Spotlights These 3 Stocks in Its Bullish S&P 500 OutlookIn a recent market update, Goldman Sachs raised its year-end forecast for the S&P 500 (SPX) to 6,900 by year-end, up from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results